Dupixent

Dupixent (dupilumab) is a prescription medication used to treat Eczema, asthma, nasal polyps. Dupixent is a biologic that treats moderate-to-severe eczema (atopic dermatitis), asthma, and nasal polyps by targeting key drivers of type 2 inflammation.

Dupixent blocks the signaling of two proteins, IL-4 and IL-13, that drive type 2 inflammation. This helps reduce the overactive immune response responsible for eczema flares, asthma attacks, and nasal polyps.

Commonly reported side effects of Dupixent include Injection site reactions, Eye inflammation (conjunctivitis), Cold sores, and Eosinophilia. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Dupixent does not carry an FDA Boxed Warning, but every prescription medicine has risks and possible interactions. Always follow your doctor's instructions and read the medication guide that comes with it.

The active ingredient in Dupixent is dupilumab, which belongs to a class of medicines known as IL-4/IL-13 Inhibitor (Biologic).

Dupixent is manufactured by Sanofi/Regeneron. It was first approved in 2017.

You may be able to lower the cost of Dupixent by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.